134 related articles for article (PubMed ID: 34990751)
21. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
[TBL] [Abstract][Full Text] [Related]
22. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
[TBL] [Abstract][Full Text] [Related]
23. ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.
Moser C; Lang SA; Mori A; Hellerbrand C; Schlitt HJ; Geissler EK; Fogler WE; Stoeltzing O
BMC Cancer; 2008 Jul; 8():206. PubMed ID: 18651980
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of tumour angiogenesis and growth by small hairpin HIF-1α and IL-8 in hepatocellular carcinoma.
Choi SH; Kwon OJ; Park JY; Kim DY; Ahn SH; Kim SU; Ro SW; Kim KS; Park JH; Kim S; Yun CO; Han KH
Liver Int; 2014 Apr; 34(4):632-42. PubMed ID: 24321089
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia A Typical Target in Human Lung Cancer Therapy.
Ullah A; Shehzadi S; Ullah N; Nawaz T; Iqbal H; Aziz T
Curr Protein Pept Sci; 2024; 25(5):376-385. PubMed ID: 38031268
[TBL] [Abstract][Full Text] [Related]
26. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells.
Tak E; Lee S; Lee J; Rashid MA; Kim YW; Park JH; Park WS; Shokat KM; Ha J; Kim SS
J Hepatol; 2011 Feb; 54(2):328-39. PubMed ID: 21056497
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia inducible factors in hepatocellular carcinoma.
Chen C; Lou T
Oncotarget; 2017 Jul; 8(28):46691-46703. PubMed ID: 28493839
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial UQCC3 Modulates Hypoxia Adaptation by Orchestrating OXPHOS and Glycolysis in Hepatocellular Carcinoma.
Yang Y; Zhang G; Guo F; Li Q; Luo H; Shu Y; Shen Y; Gan J; Xu L; Yang H
Cell Rep; 2020 Nov; 33(5):108340. PubMed ID: 33147459
[TBL] [Abstract][Full Text] [Related]
29. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.
Leung CO; Wong CC; Fan DN; Kai AK; Tung EK; Xu IM; Ng IO; Lo RC
Oncotarget; 2015 May; 6(13):10880-92. PubMed ID: 25834102
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma.
Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L
Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway.
Kung-Chun Chiu D; Pui-Wah Tse A; Law CT; Ming-Jing Xu I; Lee D; Chen M; Kit-Ho Lai R; Wai-Hin Yuen V; Wing-Sum Cheu J; Wai-Hung Ho D; Wong CM; Zhang H; Oi-Lin Ng I; Chak-Lui Wong C
Cell Death Dis; 2019 Dec; 10(12):934. PubMed ID: 31819034
[TBL] [Abstract][Full Text] [Related]
32. Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling.
Zhang JG; Zhou HM; Zhang X; Mu W; Hu JN; Liu GL; Li Q
BMC Cancer; 2020 Jan; 20(1):32. PubMed ID: 31931758
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11.
Fan Z; Yang G; Zhang W; Liu Q; Liu G; Liu P; Xu L; Wang J; Yan Z; Han H; Liu R; Shu M
J Cell Mol Med; 2021 Nov; 25(21):10197-10212. PubMed ID: 34609072
[TBL] [Abstract][Full Text] [Related]
34. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop.
Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL
Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134
[TBL] [Abstract][Full Text] [Related]
35. AQP9 suppresses hepatocellular carcinoma cell invasion through inhibition of hypoxia-inducible factor 1α expression under hypoxia.
Qian Y; Liu F; Zhang W; Zheng X; Liao S; Lv L; Mei Z
J Gastroenterol Hepatol; 2020 Nov; 35(11):1990-1997. PubMed ID: 32115773
[TBL] [Abstract][Full Text] [Related]
36. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
Zeng Z; Shi Z; Liu Y; Zhao J; Lu Q; Guo J; Liu X; Huang D; Xu Q
Biochem Biophys Res Commun; 2021 Aug; 566():80-86. PubMed ID: 34118595
[TBL] [Abstract][Full Text] [Related]
37. Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone.
Gao YB; Xiang ZL; Zhou LY; Wu ZF; Fan J; Zeng HY; Zeng ZC
J Cancer Res Clin Oncol; 2013 Apr; 139(4):669-79. PubMed ID: 23307318
[TBL] [Abstract][Full Text] [Related]
38. Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma.
Vandewynckel YP; Laukens D; Devisscher L; Bogaerts E; Paridaens A; Van den Bussche A; Raevens S; Verhelst X; Van Steenkiste C; Jonckx B; Libbrecht L; Geerts A; Carmeliet P; Van Vlierberghe H
BMC Cancer; 2016 Jan; 16():9. PubMed ID: 26753564
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia promotes the migration and invasion of human hepatocarcinoma cells through the HIF-1α-IL-8-Akt axis.
Fei M; Guan J; Xue T; Qin L; Tang C; Cui G; Wang Y; Gong H; Feng W
Cell Mol Biol Lett; 2018; 23():46. PubMed ID: 30258464
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma.
Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L
J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]